Literature DB >> 11872185

Triptans: are they all the same?

Tamara Pringsheim1, Marek Gawel.   

Abstract

The triptans have provided a major advance in the treatment of the pain and disability associated with migraine headache. With seven triptans in use or in clinical development, the clinician is faced with the decision of which triptan to prescribe to the patient with migraine. Although the triptans are pharmacologically similar, they each have unique attributes. This article focuses on the pharmacologic differences between triptans with regard to their pharmacokinetics and drug interactions, and provides some helpful tips on how to optimize migraine treatment with the triptans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872185     DOI: 10.1007/s11916-002-0010-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  26 in total

1.  Oral zolmitriptan is effective in the acute treatment of cluster headache.

Authors:  A Bahra; M J Gawel; J E Hardebo; D Millson; S A Breen; P J Goadsby
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

2.  Plasma serotonin in migraine and stress.

Authors:  M Anthony; H Hinterberger; J W Lance
Journal:  Arch Neurol       Date:  1967-05

3.  Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.

Authors:  R Ryan; A Elkind; C C Baker; W Mullican; S DeBussey; M Asgharnejad
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 4.  A systematic review of the use of triptans in acute migraine.

Authors:  M J Gawel; I Worthington; A Maggisano
Journal:  Can J Neurol Sci       Date:  2001-02       Impact factor: 2.104

Review 5.  The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

Authors:  E Hamel
Journal:  Can J Neurol Sci       Date:  1999-11       Impact factor: 2.104

6.  Serotonin syndrome complicating migraine pharmacotherapy.

Authors:  N T Mathew; G E Tietjen; C Lucker
Journal:  Cephalalgia       Date:  1996-08       Impact factor: 6.292

7.  Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.

Authors:  S Stark; E L Spierings; S McNeal; G P Putnam; C P Bolden-Watson; S O'Quinn
Journal:  Headache       Date:  2000 Jul-Aug       Impact factor: 5.887

Review 8.  Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).

Authors:  P Rolan
Journal:  Cephalalgia       Date:  1997-10       Impact factor: 6.292

Review 9.  Eletriptan.

Authors:  M J Gawel; N N Grujich
Journal:  Expert Opin Investig Drugs       Date:  2001-10       Impact factor: 6.206

10.  Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.

Authors:  J Goldstein; R Ryan; K Jiang; A Getson; B Norman; G A Block; C Lines
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

View more
  2 in total

Review 1.  Newer formulations of the triptans: advances in migraine management.

Authors:  Jonathan Paul Gladstone; Marek Gawel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model.

Authors:  Anroop B Nair; Bandar E Al-Dhubiab; Jigar Shah; Shery Jacob; Vismay Saraiya; Mahesh Attimarad; Nagaraja SreeHarsha; Sabah H Akrawi; Tamer M Shehata
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.